agilon health (NYSE:AGL) Stock Price Down 5.8% – Here’s Why

agilon health, inc. (NYSE:AGL)’s share price was down 5.8% during mid-day trading on Monday . The company traded as low as $1.85 and last traded at $1.86. Approximately 572,119 shares changed hands during mid-day trading, a decline of 88% from the average daily volume of 4,825,294 shares. The stock had previously closed at $1.97.

Analyst Ratings Changes

A number of analysts have weighed in on the stock. JMP Securities lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. Barclays reduced their price target on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a research report on Monday, November 11th. Sanford C. Bernstein assumed coverage on agilon health in a research report on Wednesday, December 11th. They issued a “market perform” rating and a $2.50 price objective on the stock. Evercore ISI reduced their target price on agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a report on Tuesday, October 8th. Finally, Stifel Nicolaus dropped their target price on shares of agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a report on Tuesday, November 12th. Three research analysts have rated the stock with a sell rating, sixteen have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat, agilon health presently has a consensus rating of “Hold” and a consensus price target of $4.28.

agilon health Stock Performance

The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The company has a market capitalization of $786.95 million, a P/E ratio of -2.03 and a beta of 0.51. The business has a 50-day moving average of $2.26 and a 200-day moving average of $4.15.

agilon health (NYSE:AGL) last released its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The firm had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. During the same quarter last year, the business posted ($0.06) EPS. On average, sell-side analysts anticipate that agilon health, inc. will post -0.52 EPS for the current year.

Insider Buying and Selling at agilon health

In related news, Director Diana Mckenzie purchased 12,500 shares of the business’s stock in a transaction dated Monday, November 25th. The shares were acquired at an average cost of $2.28 per share, for a total transaction of $28,500.00. Following the acquisition, the director now owns 51,319 shares of the company’s stock, valued at $117,007.32. The trade was a 32.20 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director John William Wulf bought 45,000 shares of the stock in a transaction on Thursday, December 5th. The stock was purchased at an average price of $2.18 per share, with a total value of $98,100.00. Following the completion of the purchase, the director now owns 206,133 shares of the company’s stock, valued at $449,369.94. This represents a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased a total of 90,000 shares of company stock valued at $198,100 in the last three months. Company insiders own 3.20% of the company’s stock.

Institutional Trading of agilon health

A number of institutional investors have recently made changes to their positions in AGL. Citigroup Inc. raised its stake in agilon health by 2,251.5% in the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after buying an additional 1,941,993 shares during the last quarter. AQR Capital Management LLC boosted its stake in agilon health by 3,338.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after purchasing an additional 1,316,990 shares in the last quarter. Quantbot Technologies LP purchased a new stake in agilon health during the 3rd quarter worth approximately $1,742,000. Susquehanna Fundamental Investments LLC lifted its stake in shares of agilon health by 65.0% during the second quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock worth $5,262,000 after buying an additional 316,856 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund acquired a new position in shares of agilon health in the 2nd quarter valued at $1,849,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.